bowness pharmacy limited Company Information
Company Number
06652821
Website
http://bownesspharmacy.co.ukRegistered Address
16 daylesford road, cheadle, SK8 1LF
Industry
Retail sale of medical and orthopaedic goods (other than hearing aids) n.e.c., in specialised stores
Dispensing chemist in specialised stores
Telephone
01616548534
Next Accounts Due
June 2024
Group Structure
View All
Shareholders
abk corporation limited 100%
bowness pharmacy limited Estimated Valuation
The estimated valuation range for bowness pharmacy limited, derived from financial data as of September 2022 and the most recent industry multiples, is between £293.2k to £1.3m
bowness pharmacy limited Estimated Valuation
The estimated valuation range for bowness pharmacy limited, derived from financial data as of September 2022 and the most recent industry multiples, is between £293.2k to £1.3m
bowness pharmacy limited Estimated Valuation
The estimated valuation range for bowness pharmacy limited, derived from financial data as of September 2022 and the most recent industry multiples, is between £293.2k to £1.3m
Get a detailed valuation report, edit figures and unlock valuation multiples.
Bowness Pharmacy Limited AI Business Plan
In just minutes, we combine Pomanda’s company and industry data with cutting edge Artificial Intelligence to build a comprehensive 27 section business plan. You then have 60 days to tailor the information, decide which sections to include or exclude, and add your own branding logos, images and color scheme to create your perfect plan.
Bowness Pharmacy Limited Overview
Bowness Pharmacy Limited is a live company located in cheadle, SK8 1LF with a Companies House number of 06652821. It operates in the dispensing chemist in specialised stores sector, SIC Code 47730. Founded in July 2008, it's largest shareholder is abk corporation limited with a 100% stake. Bowness Pharmacy Limited is a established, small sized company, Pomanda has estimated its turnover at £2.2m with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Bowness Pharmacy Limited Health Check
Pomanda's financial health check has awarded Bowness Pharmacy Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 6 areas for improvement. Company Health Check FAQs
3 Strong
3 Regular
6 Weak
Size
annual sales of £2.2m, make it smaller than the average company (£10.9m)
- Bowness Pharmacy Limited
£10.9m - Industry AVG
Growth
3 year (CAGR) sales growth of -5%, show it is growing at a slower rate (4.9%)
- Bowness Pharmacy Limited
4.9% - Industry AVG
Production
with a gross margin of 36.6%, this company has a comparable cost of product (36.6%)
- Bowness Pharmacy Limited
36.6% - Industry AVG
Profitability
an operating margin of 2.5% make it less profitable than the average company (5.2%)
- Bowness Pharmacy Limited
5.2% - Industry AVG
Employees
with 20 employees, this is below the industry average (55)
20 - Bowness Pharmacy Limited
55 - Industry AVG
Pay Structure
on an average salary of £35.3k, the company has an equivalent pay structure (£35.3k)
- Bowness Pharmacy Limited
£35.3k - Industry AVG
Efficiency
resulting in sales per employee of £110.8k, this is less efficient (£196.8k)
- Bowness Pharmacy Limited
£196.8k - Industry AVG
Debtor Days
it gets paid by customers after 31 days, this is earlier than average (43 days)
- Bowness Pharmacy Limited
43 days - Industry AVG
Creditor Days
its suppliers are paid after 137 days, this is slower than average (52 days)
- Bowness Pharmacy Limited
52 days - Industry AVG
Stock Days
it holds stock equivalent to 21 days, this is less than average (41 days)
- Bowness Pharmacy Limited
41 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 7 weeks, this is less cash available to meet short term requirements (19 weeks)
7 weeks - Bowness Pharmacy Limited
19 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 63.4%, this is a similar level of debt than the average (59%)
63.4% - Bowness Pharmacy Limited
59% - Industry AVG
bowness pharmacy limited Credit Report and Business Information
Bowness Pharmacy Limited Competitor Analysis
Perform a competitor analysis for bowness pharmacy limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.
bowness pharmacy limited Ownership
BOWNESS PHARMACY LIMITED group structure
Bowness Pharmacy Limited has no subsidiary companies.
bowness pharmacy limited directors
Bowness Pharmacy Limited currently has 4 directors. The longest serving directors include Mrs Lamya Dalal (May 2018) and Mr Zulfikar Karimjee (May 2018).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mrs Lamya Dalal | England | 32 years | May 2018 | - | Director |
Mr Zulfikar Karimjee | England | 61 years | May 2018 | - | Director |
Mr Alihussein Dalal | United Kingdom | 38 years | May 2018 | - | Director |
Mr Shamoil Karimjee | England | 36 years | Mar 2021 | - | Director |
BOWNESS PHARMACY LIMITED financials
Bowness Pharmacy Limited's latest turnover from September 2022 is estimated at £2.2 million and the company has net assets of £558.7 thousand. According to their latest financial statements, Bowness Pharmacy Limited has 20 employees and maintains cash reserves of £118.4 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | May 2018 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | |||||||||||||
Other Income Or Grants | |||||||||||||
Cost Of Sales | |||||||||||||
Gross Profit | |||||||||||||
Admin Expenses | |||||||||||||
Operating Profit | |||||||||||||
Interest Payable | 8,226 | 11,422 | |||||||||||
Interest Receivable | |||||||||||||
Pre-Tax Profit | |||||||||||||
Tax | |||||||||||||
Profit After Tax | |||||||||||||
Dividends Paid | |||||||||||||
Retained Profit | |||||||||||||
Employee Costs | 271,649 | 266,858 | |||||||||||
Number Of Employees | 20 | 20 | 20 | 20 | 20 | 21 | |||||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | May 2018 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 383,032 | 406,393 | 257,548 | 260,366 | 126,601 | 21,360 | 21,943 | 24,680 | 29,411 | 35,277 | 30,436 | 21,686 | 22,625 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 191,824 | 264,283 | 246,347 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 383,032 | 406,393 | 257,548 | 260,366 | 126,601 | 213,184 | 286,226 | 271,027 | 29,411 | 35,277 | 30,436 | 21,686 | 22,625 |
Stock & work in progress | 82,500 | 81,250 | 80,200 | 82,500 | 85,409 | 84,394 | 79,523 | 78,171 | 74,605 | 65,790 | 53,999 | 28,684 | 20,453 |
Trade Debtors | 188,617 | 435,067 | 357,069 | 397,430 | 321,152 | 167,221 | 190,050 | 251,367 | 178,005 | 162,580 | 133,536 | 65,734 | 53,541 |
Group Debtors | 689,127 | 500,576 | 359,062 | 202,365 | 0 | 119,203 | 105,908 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 63,375 | 62,687 | 63,758 | 59,140 | 44,186 | 25,927 | 28,037 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash | 118,358 | 3,482 | 14,979 | 24,559 | 1,085 | 57,682 | 1,541 | 49,373 | 154,241 | 117,036 | 126,629 | 175,943 | 59,693 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 1,141,977 | 1,083,062 | 875,068 | 765,994 | 451,832 | 454,427 | 405,059 | 378,911 | 406,851 | 345,406 | 314,164 | 270,361 | 133,687 |
total assets | 1,525,009 | 1,489,455 | 1,132,616 | 1,026,360 | 578,433 | 667,611 | 691,285 | 649,938 | 436,262 | 380,683 | 344,600 | 292,047 | 156,312 |
Bank overdraft | 0 | 6,310 | 69 | 46,309 | 24,888 | 22,522 | 38,212 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 531,131 | 507,382 | 461,896 | 511,284 | 301,199 | 310,114 | 344,150 | 358,738 | 329,202 | 276,162 | 0 | 0 | 110,006 |
Group/Directors Accounts | 35,000 | 0 | 0 | 0 | 0 | 472 | 972 | 0 | 0 | 0 | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 1,401 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 236,869 | 253,609 | 248,491 | 177,974 | 44,221 | 41,673 | 20,888 | 0 | 0 | 0 | 200,023 | 160,373 | 0 |
total current liabilities | 803,000 | 767,301 | 710,456 | 735,567 | 370,308 | 376,182 | 404,222 | 358,738 | 329,202 | 276,162 | 200,023 | 160,373 | 110,006 |
loans | 37,500 | 47,500 | 50,000 | 0 | 0 | 173,263 | 196,679 | 217,641 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 123,230 | 156,195 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
provisions | 2,629 | 2,629 | 2,629 | 2,629 | 2,629 | 4,272 | 4,389 | 4,936 | 5,882 | 7,055 | 6,087 | 4,554 | 4,751 |
total long term liabilities | 163,359 | 206,324 | 52,629 | 2,629 | 2,629 | 177,535 | 201,068 | 222,577 | 5,882 | 7,055 | 6,087 | 4,554 | 4,751 |
total liabilities | 966,359 | 973,625 | 763,085 | 738,196 | 372,937 | 553,717 | 605,290 | 581,315 | 335,084 | 283,217 | 206,110 | 164,927 | 114,757 |
net assets | 558,650 | 515,830 | 369,531 | 288,164 | 205,496 | 113,894 | 85,995 | 68,623 | 101,178 | 97,466 | 138,490 | 127,120 | 41,555 |
total shareholders funds | 558,650 | 515,830 | 369,531 | 288,164 | 205,496 | 113,894 | 85,995 | 68,623 | 101,178 | 97,466 | 138,490 | 127,120 | 41,555 |
Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | May 2018 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||
Operating Profit | |||||||||||||
Depreciation | 28,661 | 29,456 | 14,288 | 21,581 | 8,036 | 6,085 | 5,163 | 5,847 | 7,376 | 8,933 | 7,551 | 5,153 | 4,652 |
Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax | |||||||||||||
Stock | 1,250 | 1,050 | -2,300 | -2,909 | 85,409 | 4,871 | 1,352 | 3,566 | 8,815 | 11,791 | 25,315 | 8,231 | 20,453 |
Debtors | -57,211 | 218,441 | 120,954 | 293,597 | 365,338 | -84,103 | 90,564 | 319,709 | 15,425 | 29,044 | 67,802 | 12,193 | 53,541 |
Creditors | 23,749 | 45,486 | -49,388 | 210,085 | 301,199 | -34,036 | -14,588 | 29,536 | 53,040 | 276,162 | 0 | -110,006 | 110,006 |
Accruals and Deferred Income | -16,740 | 5,118 | 70,517 | 133,753 | 44,221 | 20,785 | 20,888 | 0 | 0 | -200,023 | 39,650 | 160,373 | 0 |
Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 2,629 | -117 | -547 | -946 | -1,173 | 968 | 1,533 | -197 | 4,751 |
Cash flow from operations | |||||||||||||
Investing Activities | |||||||||||||
capital expenditure | |||||||||||||
Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
cash flow from investments | |||||||||||||
Financing Activities | |||||||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 35,000 | 0 | 0 | 0 | 0 | -500 | 972 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | -10,000 | -2,500 | 50,000 | 0 | 0 | -23,416 | -20,962 | 217,641 | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 1,401 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | -32,965 | 156,195 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
share issue | |||||||||||||
interest | |||||||||||||
cash flow from financing | |||||||||||||
cash and cash equivalents | |||||||||||||
cash | 114,876 | -11,497 | -9,580 | 23,474 | 1,085 | 56,141 | -47,832 | -104,868 | 37,205 | -9,593 | -49,314 | 116,250 | 59,693 |
overdraft | -6,310 | 6,241 | -46,240 | 21,421 | 24,888 | -15,690 | 38,212 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | 121,186 | -17,738 | 36,660 | 2,053 | -23,803 | 71,831 | -86,044 | -104,868 | 37,205 | -9,593 | -49,314 | 116,250 | 59,693 |
P&L
September 2022turnover
2.2m
-29%
operating profit
55.3k
0%
gross margin
36.6%
+9.67%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
September 2022net assets
558.7k
+0.08%
total assets
1.5m
+0.02%
cash
118.4k
+32.99%
net assets
Total assets minus all liabilities
bowness pharmacy limited company details
company number
06652821
Type
Private limited with Share Capital
industry
47749 - Retail sale of medical and orthopaedic goods (other than hearing aids) n.e.c., in specialised stores
47730 - Dispensing chemist in specialised stores
incorporation date
July 2008
age
16
accounts
Total Exemption Full
ultimate parent company
previous names
N/A
incorporated
UK
address
16 daylesford road, cheadle, SK8 1LF
last accounts submitted
September 2022
bowness pharmacy limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 5 charges/mortgages relating to bowness pharmacy limited. Currently there are 3 open charges and 2 have been satisfied in the past.
bowness pharmacy limited Companies House Filings - See Documents
date | description | view/download |
---|